CAS NO: | 1357171-62-0 |
生物活性 | ML228 (CID-46742353) is a potent theHypoxia Inducible Factor (HIF)pathway activator withEC50of 1 μM. ML228 potently activates HIF in vitro as well as its downstream targetVEGF[1][2]. | ||||||||||||||||
IC50& Target | EC50: 1 μM (HIF)[1] | ||||||||||||||||
体外研究 (In Vitro) | ML228 (CID-46742353) represents a novel chemotype available to the research community for the study of HIF activation and its therapeutic potential. Not only is the compound substantially different in structure from known HIF activators, ML228 lacks the acidic functional group almost universally present in PHD inhibitors, which may be important for certain disease applications[1][2]. | ||||||||||||||||
体内研究 (In Vivo) | ML228 (injection; 1 μg/kg; 7 days) treatments following spinal cord injury (SCI) improves the local hypoxic ischemia environment, reduce SCI secondary injury and promote the recovery of neurological function[3].
| ||||||||||||||||
分子量 | 415.49 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C27H21N5 | ||||||||||||||||
CAS 号 | 1357171-62-0 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 35 mg/mL(84.24 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |